-
Prediction and prevention of small-for-gestational-age neonates: evidence from SPREE and ASPRE.
Tan MY, Poon LC, Rolnik DL, Syngelaki A, de Paco Matallana C, Akolekar R, Cicero S, Janga D, Singh M, Molina FS, Persico N, Jani JC, Plasencia W, Greco E, Papaioannou G, Wright D, Nicolaides KH.
Ultrasound Obstet Gynecol 2018;52:52-59. pdf -
Maternal Serum Placental Growth Factor (PlGF) Isoforms 1 and 2 at 11-13 Weeks' Gestation in Normal and Pathological Pregnancies.
Nucci M, Poon LC, Demirdjian G, Darbouret B, Nicolaides KH.
Fetal Diagn Ther 2014;36:106-16.. pdf -
Low-dose aspirin for prevention of adverse outcomes related to abnormal placentation.
Bujold E, Roberge S, Nicolaides KH.
Prenat Diagn 2014;34:642-8. pdf -
Megacystis at 10-14 weeks of gestation: chromosomal defects and outcome according to bladder length.
Liao AW, Sebire NJ, Geerts L, Cicero S, Nicolaides KH.
Ultrasound Obstet Gynecol 2003;21:338-41. -
Fetal megacystis at 10-14 weeks of gestation.
Sebire NJ, Von Kaisenberg C, Rubio C, Nicolaides KH.
Ultrasound Obstet Gynecol 1996;8:387-90. -
Fetal mild hydronephrosis and chromosomal defects: relation to maternal age and gestation.
Snijders RJ, Sebire NJ, Faria M, Patel F, Nicolaides KH.
Fetal Diagn Ther 1995;10:349-55.